Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients

BACKGROUND: To investigate whether the serum free thyroxine (FT4) level is a prognostic factor for the first-attack neuromyelitis optica spectrum disorders (NMOSD). METHODS: This retrospective study enrolled 109 patients with first-attack NMOSD. The Expanded Disability Status Scale (EDSS) and the re...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qianyi, Li, Lifeng, Li, Yanfei, Lu, Yanhui, Wu, Kaimin, Zhang, Ruiyi, Teng, Junfang, Zhao, Jie, Jia, Yanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921452/
https://www.ncbi.nlm.nih.gov/pubmed/31852443
http://dx.doi.org/10.1186/s12883-019-1560-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921452/
https://www.ncbi.nlm.nih.gov/pubmed/31852443
http://dx.doi.org/10.1186/s12883-019-1560-7

Ejemplares similares